Vemzatatug
Vemzatatug is a humanized IgG1κ monoclonal antibody inhibitor targeting GPRC5D. Vemzatatug has an antitumor activity. Vemzatatug can be used for cancers like multiple myeloma (MM) research[1][2].
Product Specifications
CAS Number
[3035714-52-1]
UNSPSC
12352100
Target
Orphan GPCR
Related Pathways
GPCR/G Protein
Applications
Cancer-programmed cell death
Field of Research
Cancer
References & Citations
[1]Rodriguez-Otero P, et al. GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review. Blood Cancer J. 2024 Feb 2;14 (1) :24. doi: 10.1038/s41408-023-00966-9. Erratum in: Blood Cancer J. 2024 Mar 6;14 (1) :40. |[2]Internacionales D C. International Nonproprietary Names for Pharmaceutical Substances (INN) [J]. WHO Drug Information, 2025, 39 (2) .
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7079284 Inquire
Recombinant Pseudomonas fluorescens UPF0060 membrane protein Pfl01_4105 (Pfl01_4105), partial
Ask
View Details 
MBS1180593-01 0.02 mg (E-Coli)
Recombinant Rickettsia peacockii N utilization substance protein B homolog (nusB)
Ask
View Details MBS1180593-02 0.1 mg (E-Coli)
Recombinant Rickettsia peacockii N utilization substance protein B homolog (nusB)
Ask
View Details